CREATINE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 131.0 | -1.1 | 3 | 2 | 90.0 | 2 | 0.5 |
- CAS
- 57001
- UNII
- MU72812GK0
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 69 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT00005674 | Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS] | Phase 2 | Completed | |
| NCT00018109 | A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD) | Phase 3 | Completed | |
| NCT02374112 | 2016-01-01 | Creatine Supplementation in Chronic Fatigue Syndrome | Phase 2 | Enrolling By Invitation |
| NCT02356107 | 2015-04-01 | 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females | Phase 4 | Not Yet Recruiting |
| NCT02188849 | 2014-10-01 | Effects of Creatine Supplementation on Muscle Mass and Function Among Older Women Subjected to Resistance Training | Phase 3 | Not Yet Recruiting |
| NCT02047864 | 2014-01-01 | Effect of Creatine Supplementation and Exercise on Bone Health | Phase 3 | Recruiting |
| NCT02058654 | 2013-12-01 | A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population | Phase 1 | Completed |
| NCT02094781 | 2013-12-01 | Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males | Phase 1 | Completed |
| NCT01514630 | 2013-01-01 | Creatine as a Treatment Option for Depression in Methamphetamine Using Females | Phase 4 | Recruiting |
| NCT01175616 | 2012-09-01 | Creatine Augmentation in Veterans With SSRI-Resistant Major Depression | Phase 2 | Completed |
| NCT01655030 | 2012-07-01 | Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression | Phase 4 | Not Yet Recruiting |
| NCT01601210 | 2012-06-01 | Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder | Phase 4 | Completed |
| NCT01257581 | 2011-03-01 | Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Completed |
| NCT01381354 | 2010-10-01 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | Phase 1 | Active, Not Recruiting |
| NCT01050556 | 2010-09-01 | Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic | Phase 4 | Completed |
| NCT01411163 | 2010-04-01 | Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability | Phase 2 | Completed |
| NCT01057680 | 2010-01-01 | Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone | Phase 3 | Completed |
| NCT00712426 | 2009-09-01 | Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) | Phase 3 | Terminated |
| NCT01411150 | 2009-05-01 | Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study | Phase 2 | Completed |
| NCT00851006 | 2009-04-01 | Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram | Phase 2 | Completed |
| NCT00592995 | 2007-12-01 | Creatine Safety and Tolerability in Premanifest HD: PRECREST | Phase 2 | Completed |
| NCT00449865 | 2007-03-01 | NET-PD LS-1 Creatine in Parkinson's Disease | Phase 3 | Terminated |
| NCT00313417 | 2007-01-01 | Creatine as a New Therapeutic Strategy in Depression | Phase 4 | Terminated |
| NCT00355576 | 2006-07-01 | Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis | Phase 2 | Completed |
| NCT01412151 | 2005-04-01 | Creatine Safety & Tolerability in Huntington's Disease | Phase 2 | Completed |
| NCT00081250 | 2004-12-01 | Creatine in Treating Patients With Cancer-Associated Weight Loss | Phase 3 | Active, Not Recruiting |
| NCT00140192 | 2004-09-01 | Creatine Treatment in Psychiatric Disorders | Phase 3 | Completed |
| NCT00605930 | 2004-04-01 | A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. | Phase 1 | Completed |
| NCT00069186 | 2003-06-01 | Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis | Phase 3 | Active, Not Recruiting |
| NCT00063193 | 2003-05-01 | National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial | Phase 2 | Completed |
| NCT00070993 | 2002-12-01 | Creatine for the Treatment of Amyotrophic Lateral Sclerosis | Phase 2 | Completed |
| NCT00026988 | 2001-10-01 | Creatine Therapy for Huntington's Disease | Phase 1/Phase 2 | Completed |
| NCT00484627 | 2001-08-01 | Effects of Creatine and Resistance Exercise Training in People With HIV Infection | Phase 2 | Completed |
| NCT00016653 | 2000-06-01 | Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy | Phase 2/Phase 3 | Completed |